CSL vs. GMAB
CSL (Carlisle Companies Incorporated) and GMAB (Genmab A/S) are both stocks. CSL operates in Building Products & Equipment (Industrials), while GMAB operates in Biotechnology (Healthcare). Over the past 10 years, CSL returned 14.57%/yr vs 4.28%/yr for GMAB. At a 0.17 correlation, their price movements are largely independent.
Performance
CSL vs. GMAB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CSL achieves a 8.12% return, which is significantly higher than GMAB's -18.57% return. Over the past 10 years, CSL has outperformed GMAB with an annualized return of 14.57%, while GMAB has yielded a comparatively lower 4.28% annualized return.
CSL
- 1D
- 0.82%
- 1M
- 4.26%
- YTD
- 8.12%
- 6M
- 4.47%
- 1Y
- -2.49%
- 3Y*
- 14.36%
- 5Y*
- 13.87%
- 10Y*
- 14.57%
GMAB
- 1D
- -0.63%
- 1M
- -5.50%
- YTD
- -18.57%
- 6M
- -19.90%
- 1Y
- 9.90%
- 3Y*
- -13.28%
- 5Y*
- -10.53%
- 10Y*
- 4.28%
CSL vs. GMAB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CSL Carlisle Companies Incorporated | 8.12% | -12.26% | 19.14% | 34.26% | -4.08% | 60.64% | -1.96% | 63.10% | -10.31% | 4.51% |
GMAB Genmab A/S | -18.57% | 47.58% | -34.45% | -24.87% | 7.13% | -2.71% | 82.09% | 35.54% | -0.61% | -0.04% |
Correlation
The correlation between CSL and GMAB is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.24 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Jun 1, 2009 | 0.17 |
The correlation between CSL and GMAB shifts across timeframes, from 0.17 (all time) to 0.27 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
CSL:
$14.13B
GMAB:
$16.01B
CSL:
$17.08
GMAB:
$4.10
CSL:
20.13
GMAB:
6.12
CSL:
0.52
GMAB:
0.41
CSL:
2.93
GMAB:
1.81
CSL:
8.55
GMAB:
2.82
CSL:
$4.98B
GMAB:
$8.84B
CSL:
$1.41B
GMAB:
$8.27B
CSL:
$1.17B
GMAB:
$3.81B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CSL vs. GMAB — Risk / Return Rank
CSL
GMAB
CSL vs. GMAB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Carlisle Companies Incorporated (CSL) and Genmab A/S (GMAB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CSL | GMAB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.39 | ||
| Sortino ratioReturn per unit of downside risk | -0.54 | ||
| Omega ratioGain probability vs. loss probability | 1.01 | 1.07 | -0.06 |
| Calmar ratioReturn relative to maximum drawdown | -0.16 | 0.27 | -0.43 |
| Martin ratioReturn relative to average drawdown | -0.27 | 0.58 | -0.85 |
Loading charts...
Drawdowns
CSL vs. GMAB - Drawdown Comparison
The maximum CSL drawdown since its inception was -64.56%, smaller than the maximum GMAB drawdown of -84.20%. Use the drawdown chart below to compare losses from any high point for CSL and GMAB.
Loading charts...
Drawdown Indicators
| CSL | GMAB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -64.56% | -84.20% | +19.64% |
Max Drawdown (1Y)Largest decline over 1 year | -31.67% | -32.51% | +0.84% |
Max Drawdown (3Y)Largest decline over 3 years | -37.72% | -57.44% | +19.72% |
Max Drawdown (5Y)Largest decline over 5 years | -37.72% | -63.10% | +25.38% |
Max Drawdown (10Y)Largest decline over 10 years | -38.68% | -63.10% | +24.42% |
Current DrawdownCurrent decline from peak | -27.08% | -48.52% | +21.44% |
Average DrawdownAverage peak-to-trough decline | -12.32% | -31.09% | +18.77% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.90% | 14.86% | +4.04% |
Volatility
CSL vs. GMAB - Volatility Comparison
The current volatility for Carlisle Companies Incorporated (CSL) is 10.87%, while Genmab A/S (GMAB) has a volatility of 12.15%. This indicates that CSL experiences smaller price fluctuations and is considered to be less risky than GMAB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CSL | GMAB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.87% | 12.15% | -1.28% |
Volatility (6M)Calculated over the trailing 6-month period | 24.85% | 25.57% | -0.72% |
Volatility (1Y)Calculated over the trailing 1-year period | 36.22% | 34.45% | +1.77% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 30.81% | 33.47% | -2.66% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 29.68% | 35.19% | -5.51% |
Dividends
CSL vs. GMAB - Dividend Comparison
CSL's dividend yield for the trailing twelve months is around 1.28%, while GMAB has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CSL Carlisle Companies Incorporated | 1.28% | 1.31% | 1.00% | 1.02% | 1.09% | 0.86% | 1.31% | 1.11% | 1.53% | 1.27% | 1.18% | 1.24% |
GMAB Genmab A/S | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
CSL vs. GMAB - Financials Comparison
This section allows you to compare key financial metrics between Carlisle Companies Incorporated and Genmab A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CSL vs. GMAB - Profitability Comparison
CSL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Carlisle Companies Incorporated reported a gross profit of 0.00 and revenue of 1.05B. Therefore, the gross margin over that period was 0.0%.
GMAB - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Genmab A/S reported a gross profit of 834.08M and revenue of 899.32M. Therefore, the gross margin over that period was 92.8%.
CSL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Carlisle Companies Incorporated reported an operating income of 180.30M and revenue of 1.05B, resulting in an operating margin of 17.1%.
GMAB - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Genmab A/S reported an operating income of 225.83M and revenue of 899.32M, resulting in an operating margin of 25.1%.
CSL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Carlisle Companies Incorporated reported a net income of 127.70M and revenue of 1.05B, resulting in a net margin of 12.1%.
GMAB - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Genmab A/S reported a net income of 53.20M and revenue of 899.32M, resulting in a net margin of 5.9%.
Frequently Asked Questions
CSL and GMAB have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GMAB has higher volatility (12.15%) compared to CSL (10.87%). In terms of maximum drawdown, CSL dropped -64.56% vs GMAB's -84.20%.
GMAB currently has the higher Sharpe Ratio (0.25 vs -0.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CSL and GMAB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer